Crossmark

Anti‐tumor efficacy of a novel CLK inhibitor via targeting RNA splicing and MYC‐dependent vulnerability

Crossref DOI link: https://doi.org/10.15252/emmm.201708289

Published Online: 2018-05-16

Published Print: 2018-06

Update policy: https://doi.org/10.1002/crossmark_policy

Authors

Iwai, Kenichi

Yaguchi, Masahiro

Nishimura, Kazuho

Yamamoto, Yukiko

Tamura, Toshiya

Nakata, Daisuke

Dairiki, Ryo

Kawakita, Yoichi

Mizojiri, Ryo

Ito, Yoshiteru

Asano, Moriteru

Maezaki, Hironobu

Nakayama, Yusuke

Kaishima, Misato

Hayashi, Kozo

Teratani, Mika

Miyakawa, Shuichi

Iwatani, Misa

Miyamoto, Maki

Klein, Michael G

Lane, Wes

Snell, Gyorgy

Tjhen, Richard

He, Xingyue

Pulukuri, Sai

Nomura, Toshiyuki https://orcid.org/0000-0003-4122-0301
License Information

Version of Record valid from 2018-05-16
More Information

Publication History

Received: 2017-07-18

Accepted: 2018-04-18

Published: 2018-05-16